Scientists create massive biobank to uncover lung Cancer's earliest clues

NCT ID NCT00340405

Completed Knowledge-focused Sponsor: National Cancer Institute (NCI) Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 29, 2026 · Updated 4 times

Summary

This study collected and stored biological samples from nearly 10,000 tin miners in China who are at high risk for lung cancer due to workplace exposures. The goal is to use these samples to discover early markers of the disease, which could lead to better screening and prevention strategies. Participants provided sputum, blood, urine, and other specimens over time, and researchers will follow them to see who develops lung cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to detect lung cancer early in high-risk groups, potentially saving lives through earlier treatment.
What could go wrong: This is an observational study that builds a resource for future research. It does not test a treatment, so direct benefits for participants are not expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

Cancer Institute of the Chinese Academy of Medical Sciences

Beijing, 100021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.